181 related articles for article (PubMed ID: 30642445)
1. Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial-mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma.
Neri S; Menju T; Sowa T; Yutaka Y; Nakajima D; Hamaji M; Ohsumi A; Chen-Yoshikawa TF; Sato T; Sonobe M; Yoshizawa A; Haga H; Date H
Lung Cancer; 2019 Feb; 128():13-19. PubMed ID: 30642445
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
4. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
[TBL] [Abstract][Full Text] [Related]
5. Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller.
Seok Y; Lee E
Thorac Cardiovasc Surg; 2018 Mar; 66(2):150-155. PubMed ID: 27517168
[TBL] [Abstract][Full Text] [Related]
6. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
[TBL] [Abstract][Full Text] [Related]
8. Extent of visceral pleural invasion and the prognosis of surgically resected node-negative non-small cell lung cancer.
Seok Y; Jeong JY; Lee E
Thorac Cancer; 2017 May; 8(3):197-202. PubMed ID: 28220643
[TBL] [Abstract][Full Text] [Related]
9. Recurrence Pattern of Pathologic Stage I Lung Adenocarcinoma With Visceral Pleural Invasion.
Jiwangga D; Cho S; Kim K; Jheon S
Ann Thorac Surg; 2017 Apr; 103(4):1126-1131. PubMed ID: 27993377
[TBL] [Abstract][Full Text] [Related]
10. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of visceral pleural invasion in pure-solid and part-solid lung cancer patients.
Okada S; Hattori A; Matsunaga T; Takamochi K; Oh S; Inoue M; Suzuki K
Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):303-310. PubMed ID: 32918675
[TBL] [Abstract][Full Text] [Related]
12. Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma.
Nitadori JI; Colovos C; Kadota K; Sima CS; Sarkaria IS; Rizk NP; Rusch VW; Travis WD; Adusumilli PS
Chest; 2013 Nov; 144(5):1622-1631. PubMed ID: 23807749
[TBL] [Abstract][Full Text] [Related]
13. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
Koh YW; Han JH; Jeong D; Kim CJ
Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance and prognostic value of CT-defined visceral pleural invasion in early-stage lung adenocarcinomas.
Lim WH; Lee KH; Lee JH; Park H; Nam JG; Hwang EJ; Chung JH; Goo JM; Park S; Kim YT; Kim H
Eur Radiol; 2024 Mar; 34(3):1934-1945. PubMed ID: 37658899
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of visceral pleural invasion in the stage pT
Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Impact of the Findings on Thin-Section Computed Tomography in stage I lung adenocarcinoma with visceral pleural invasion.
Yuan M; Liu JY; Zhang T; Zhang YD; Li H; Yu TF
Sci Rep; 2018 Mar; 8(1):4743. PubMed ID: 29549366
[TBL] [Abstract][Full Text] [Related]
18. Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database.
Kawase A; Yoshida J; Miyaoka E; Asamura H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
J Thorac Oncol; 2013 May; 8(5):606-11. PubMed ID: 23478542
[TBL] [Abstract][Full Text] [Related]
19. Use of Autofluorescence to Intraoperatively Diagnose Visceral Pleural Invasion From Frozen Sections in Patients With Lung Adenocarcinoma 2 cm or Less.
Xie H; Su H; Chen D; Xie D; Dai C; Ren Y; She Y; Xu L; Zhao S; Wu C; Jiang G; Chen C
Am J Clin Pathol; 2019 Oct; 152(5):608-615. PubMed ID: 31305894
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
